nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—Application site erythema—Tretinoin—peripheral nervous system neoplasm	0.0217	0.0616	CcSEcCtD
Ingenol Mebutate—Application site erythema—Isotretinoin—peripheral nervous system neoplasm	0.0217	0.0616	CcSEcCtD
Ingenol Mebutate—Application site pruritus—Isotretinoin—peripheral nervous system neoplasm	0.021	0.0594	CcSEcCtD
Ingenol Mebutate—Application site pruritus—Tretinoin—peripheral nervous system neoplasm	0.021	0.0594	CcSEcCtD
Ingenol Mebutate—Application site erythema—Alitretinoin—peripheral nervous system neoplasm	0.0165	0.0467	CcSEcCtD
Ingenol Mebutate—Scab—Tretinoin—peripheral nervous system neoplasm	0.0161	0.0456	CcSEcCtD
Ingenol Mebutate—Scab—Isotretinoin—peripheral nervous system neoplasm	0.0161	0.0456	CcSEcCtD
Ingenol Mebutate—Application site pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0159	0.045	CcSEcCtD
Ingenol Mebutate—PRKCA—nerve—peripheral nervous system neoplasm	0.0136	0.257	CbGeAlD
Ingenol Mebutate—PRKCA—ganglion—peripheral nervous system neoplasm	0.0135	0.254	CbGeAlD
Ingenol Mebutate—Scab—Alitretinoin—peripheral nervous system neoplasm	0.0122	0.0346	CcSEcCtD
Ingenol Mebutate—PRKCD—trigeminal ganglion—peripheral nervous system neoplasm	0.012	0.226	CbGeAlD
Ingenol Mebutate—Application site pain—Tretinoin—peripheral nervous system neoplasm	0.0116	0.033	CcSEcCtD
Ingenol Mebutate—Application site pain—Isotretinoin—peripheral nervous system neoplasm	0.0116	0.033	CcSEcCtD
Ingenol Mebutate—Application site pain—Alitretinoin—peripheral nervous system neoplasm	0.00882	0.025	CcSEcCtD
Ingenol Mebutate—PRKCA—brainstem—peripheral nervous system neoplasm	0.00585	0.11	CbGeAlD
Ingenol Mebutate—Ulcer—Tretinoin—peripheral nervous system neoplasm	0.00541	0.0153	CcSEcCtD
Ingenol Mebutate—Ulcer—Isotretinoin—peripheral nervous system neoplasm	0.00541	0.0153	CcSEcCtD
Ingenol Mebutate—Ulcer—Melphalan—peripheral nervous system neoplasm	0.00534	0.0151	CcSEcCtD
Ingenol Mebutate—PRKCD—cerebellum—peripheral nervous system neoplasm	0.00523	0.0986	CbGeAlD
Ingenol Mebutate—Ulcer—Dactinomycin—peripheral nervous system neoplasm	0.00443	0.0125	CcSEcCtD
Ingenol Mebutate—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.00421	0.0119	CcSEcCtD
Ingenol Mebutate—Swelling—Tretinoin—peripheral nervous system neoplasm	0.00421	0.0119	CcSEcCtD
Ingenol Mebutate—Ulcer—Alitretinoin—peripheral nervous system neoplasm	0.0041	0.0116	CcSEcCtD
Ingenol Mebutate—Ulcer—Cisplatin—peripheral nervous system neoplasm	0.0035	0.0099	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Tretinoin—peripheral nervous system neoplasm	0.00332	0.00942	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Isotretinoin—peripheral nervous system neoplasm	0.00332	0.00942	CcSEcCtD
Ingenol Mebutate—Ulcer—Etoposide—peripheral nervous system neoplasm	0.0032	0.00907	CcSEcCtD
Ingenol Mebutate—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.00319	0.00905	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Topotecan—peripheral nervous system neoplasm	0.00289	0.00818	CcSEcCtD
Ingenol Mebutate—Infestation—Topotecan—peripheral nervous system neoplasm	0.00289	0.00818	CcSEcCtD
Ingenol Mebutate—PRKCA—cerebellum—peripheral nervous system neoplasm	0.00288	0.0544	CbGeAlD
Ingenol Mebutate—Infestation NOS—Tretinoin—peripheral nervous system neoplasm	0.00286	0.00811	CcSEcCtD
Ingenol Mebutate—Infestation—Tretinoin—peripheral nervous system neoplasm	0.00286	0.00811	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Isotretinoin—peripheral nervous system neoplasm	0.00286	0.00811	CcSEcCtD
Ingenol Mebutate—Infestation—Isotretinoin—peripheral nervous system neoplasm	0.00286	0.00811	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Tretinoin—peripheral nervous system neoplasm	0.00278	0.00789	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Isotretinoin—peripheral nervous system neoplasm	0.00278	0.00789	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.00252	0.00714	CcSEcCtD
Ingenol Mebutate—Swelling—Etoposide—peripheral nervous system neoplasm	0.00249	0.00706	CcSEcCtD
Ingenol Mebutate—Eye disorder—Tretinoin—peripheral nervous system neoplasm	0.0024	0.00681	CcSEcCtD
Ingenol Mebutate—Eye disorder—Isotretinoin—peripheral nervous system neoplasm	0.0024	0.00681	CcSEcCtD
Ingenol Mebutate—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00224	0.00634	CcSEcCtD
Ingenol Mebutate—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00224	0.00634	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Alitretinoin—peripheral nervous system neoplasm	0.00217	0.00615	CcSEcCtD
Ingenol Mebutate—Infestation—Alitretinoin—peripheral nervous system neoplasm	0.00217	0.00615	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Cisplatin—peripheral nervous system neoplasm	0.00215	0.00608	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Alitretinoin—peripheral nervous system neoplasm	0.00211	0.00598	CcSEcCtD
Ingenol Mebutate—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00183	0.00518	CcSEcCtD
Ingenol Mebutate—Infection—Topotecan—peripheral nervous system neoplasm	0.00183	0.00518	CcSEcCtD
Ingenol Mebutate—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.00182	0.00516	CcSEcCtD
Ingenol Mebutate—Infection—Tretinoin—peripheral nervous system neoplasm	0.00182	0.00514	CcSEcCtD
Ingenol Mebutate—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00182	0.00514	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00181	0.00512	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Cisplatin—peripheral nervous system neoplasm	0.0018	0.00509	CcSEcCtD
Ingenol Mebutate—Ulcer—Epirubicin—peripheral nervous system neoplasm	0.0018	0.00509	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00179	0.00508	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00179	0.00508	CcSEcCtD
Ingenol Mebutate—Infection—Melphalan—peripheral nervous system neoplasm	0.00179	0.00507	CcSEcCtD
Ingenol Mebutate—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.00481	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.00169	0.0048	CcSEcCtD
Ingenol Mebutate—Infestation—Etoposide—peripheral nervous system neoplasm	0.00169	0.0048	CcSEcCtD
Ingenol Mebutate—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.00166	0.00471	CcSEcCtD
Ingenol Mebutate—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.00155	0.0044	CcSEcCtD
Ingenol Mebutate—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00148	0.0042	CcSEcCtD
Ingenol Mebutate—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00409	CcSEcCtD
Ingenol Mebutate—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00142	0.00403	CcSEcCtD
Ingenol Mebutate—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.0039	CcSEcCtD
Ingenol Mebutate—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00387	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00385	CcSEcCtD
Ingenol Mebutate—Infection—Vincristine—peripheral nervous system neoplasm	0.00133	0.00375	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00131	0.00371	CcSEcCtD
Ingenol Mebutate—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00358	CcSEcCtD
Ingenol Mebutate—Infection—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00332	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00328	CcSEcCtD
Ingenol Mebutate—Headache—Topotecan—peripheral nervous system neoplasm	0.00115	0.00327	CcSEcCtD
Ingenol Mebutate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00324	CcSEcCtD
Ingenol Mebutate—Headache—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00324	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.0011	0.00312	CcSEcCtD
Ingenol Mebutate—Infection—Etoposide—peripheral nervous system neoplasm	0.00107	0.00304	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00289	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00095	0.00269	CcSEcCtD
Ingenol Mebutate—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00095	0.00269	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000923	0.00262	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000879	0.00249	CcSEcCtD
Ingenol Mebutate—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000879	0.00249	CcSEcCtD
Ingenol Mebutate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000867	0.00246	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000854	0.00242	CcSEcCtD
Ingenol Mebutate—Headache—Vincristine—peripheral nervous system neoplasm	0.000836	0.00237	CcSEcCtD
Ingenol Mebutate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000797	0.00226	CcSEcCtD
Ingenol Mebutate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000742	0.0021	CcSEcCtD
Ingenol Mebutate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000737	0.00209	CcSEcCtD
Ingenol Mebutate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000687	0.00195	CcSEcCtD
Ingenol Mebutate—Headache—Etoposide—peripheral nervous system neoplasm	0.000677	0.00192	CcSEcCtD
Ingenol Mebutate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000602	0.0017	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000594	0.00168	CcSEcCtD
Ingenol Mebutate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000557	0.00158	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.00156	CcSEcCtD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000467	0.000786	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD55—peripheral nervous system neoplasm	0.000465	0.000783	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—NRAS—peripheral nervous system neoplasm	0.000465	0.000783	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—ERBB2—peripheral nervous system neoplasm	0.000463	0.000779	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—ERBB2—peripheral nervous system neoplasm	0.000463	0.000779	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000459	0.000772	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—ERBB2—peripheral nervous system neoplasm	0.000459	0.000772	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000457	0.00077	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—ERBB2—peripheral nervous system neoplasm	0.000454	0.000765	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	0.000454	0.000765	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000454	0.000764	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—ERBB2—peripheral nervous system neoplasm	0.000452	0.000762	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000449	0.000755	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—HRAS—peripheral nervous system neoplasm	0.000448	0.000755	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	0.000448	0.000755	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—GNS—peripheral nervous system neoplasm	0.000448	0.000754	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic M-M/G1 phases—BIRC5—peripheral nervous system neoplasm	0.000445	0.000749	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	0.000444	0.000748	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000443	0.000746	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	0.00044	0.000742	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—AKT1—peripheral nervous system neoplasm	0.00044	0.000741	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.00044	0.000741	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	0.000438	0.000738	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000435	0.000733	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—MYC—peripheral nervous system neoplasm	0.000433	0.000729	CbGpPWpGaD
Ingenol Mebutate—PRKCA—G Protein Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000431	0.000726	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Insulin Signaling—AKT1—peripheral nervous system neoplasm	0.000429	0.000723	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	0.000427	0.000719	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000425	0.000716	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	0.000425	0.000716	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	0.000425	0.000715	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	0.000423	0.000712	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—NRAS—peripheral nervous system neoplasm	0.000422	0.000711	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—AKT1—peripheral nervous system neoplasm	0.000421	0.000709	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—AKT1—peripheral nervous system neoplasm	0.000421	0.000709	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—peripheral nervous system neoplasm	0.000419	0.000705	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.000418	0.000703	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000416	0.0007	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000415	0.0007	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000414	0.000697	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000413	0.000695	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.00041	0.000691	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—ERBB2—peripheral nervous system neoplasm	0.00041	0.00069	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IFNB1—peripheral nervous system neoplasm	0.00041	0.00069	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Regulation of mRNA stability by proteins that bind AU-rich elements—AKT1—peripheral nervous system neoplasm	0.000405	0.000682	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—NRAS—peripheral nervous system neoplasm	0.000404	0.00068	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.000404	0.00068	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000402	0.000678	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.0004	0.000674	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	0.000399	0.000672	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	0.000397	0.000669	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000396	0.000667	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	0.000396	0.000667	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—AKT1—peripheral nervous system neoplasm	0.000396	0.000667	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000395	0.000665	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	0.000392	0.000661	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—HRAS—peripheral nervous system neoplasm	0.000391	0.000658	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000389	0.000655	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	0.000387	0.000652	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—HRAS—peripheral nervous system neoplasm	0.000385	0.000649	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.000384	0.000646	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000384	0.000646	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000382	0.000643	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SLC2A1—peripheral nervous system neoplasm	0.000381	0.000641	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—NRAS—peripheral nervous system neoplasm	0.00038	0.000639	CbGpPWpGaD
Ingenol Mebutate—Headache—Epirubicin—peripheral nervous system neoplasm	0.00038	0.00108	CcSEcCtD
Ingenol Mebutate—PRKCA—Signaling by FGFR—NRAS—peripheral nervous system neoplasm	0.000378	0.000636	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—NRAS—peripheral nervous system neoplasm	0.000376	0.000633	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GNS—peripheral nervous system neoplasm	0.000375	0.000632	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—NRAS—peripheral nervous system neoplasm	0.000374	0.00063	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000372	0.000627	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000371	0.000625	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—HRAS—peripheral nervous system neoplasm	0.000364	0.000612	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000364	0.000612	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000363	0.000612	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NME1—peripheral nervous system neoplasm	0.00036	0.000606	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD34—peripheral nervous system neoplasm	0.000353	0.000594	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—NRAS—peripheral nervous system neoplasm	0.000352	0.000593	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—NRAS—peripheral nervous system neoplasm	0.000352	0.000593	CbGpPWpGaD
Ingenol Mebutate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000995	CcSEcCtD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.000351	0.00059	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—NRAS—peripheral nervous system neoplasm	0.000349	0.000587	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HGF—peripheral nervous system neoplasm	0.000346	0.000583	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—COX2—peripheral nervous system neoplasm	0.000346	0.000583	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	0.000346	0.000582	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—AKT1—peripheral nervous system neoplasm	0.000345	0.000581	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—NRAS—peripheral nervous system neoplasm	0.000344	0.00058	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—HRAS—peripheral nervous system neoplasm	0.00034	0.000573	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—AKT1—peripheral nervous system neoplasm	0.00034	0.000573	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000339	0.000571	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Metabolism of mRNA—AKT1—peripheral nervous system neoplasm	0.000334	0.000562	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	0.000333	0.00056	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	0.000331	0.000558	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—AKT1—peripheral nervous system neoplasm	0.000321	0.000541	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HGF—peripheral nervous system neoplasm	0.000316	0.000532	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	0.000315	0.000531	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000314	0.000528	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PPP3R1—peripheral nervous system neoplasm	0.000313	0.000528	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000313	0.000527	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	0.000312	0.000525	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	0.000311	0.000523	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000311	0.000523	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	0.000309	0.00052	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000309	0.000519	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000305	0.000514	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.000305	0.000514	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000301	0.000507	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000301	0.000506	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NCAM1—peripheral nervous system neoplasm	0.0003	0.000505	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—BIRC5—peripheral nervous system neoplasm	0.000297	0.000501	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—HRAS—peripheral nervous system neoplasm	0.000296	0.000498	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000287	0.000483	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—CASP3—peripheral nervous system neoplasm	0.000286	0.000482	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Metabolism of RNA—AKT1—peripheral nervous system neoplasm	0.000286	0.000481	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—HRAS—peripheral nervous system neoplasm	0.000279	0.00047	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	0.000278	0.000468	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000276	0.000465	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	0.000276	0.000465	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	0.000275	0.000463	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—HRAS—peripheral nervous system neoplasm	0.000274	0.000461	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	0.000273	0.000459	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ENO2—peripheral nervous system neoplasm	0.000271	0.000457	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.00027	0.000454	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000265	0.000445	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000263	0.000442	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	0.000261	0.000439	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	0.000258	0.000434	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—HRAS—peripheral nervous system neoplasm	0.000258	0.000434	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	0.000255	0.00043	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000253	0.000427	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	0.000253	0.000426	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000253	0.000425	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000252	0.000425	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	0.000252	0.000424	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—AKT1—peripheral nervous system neoplasm	0.000247	0.000415	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000245	0.000413	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	0.000245	0.000413	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	0.000244	0.000411	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000244	0.000411	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	0.000243	0.000409	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—AKT1—peripheral nervous system neoplasm	0.000242	0.000407	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.00024	0.000404	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000239	0.000402	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000238	0.000401	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000238	0.0004	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IFNB1—peripheral nervous system neoplasm	0.000235	0.000396	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000234	0.000394	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000234	0.000393	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PTPN11—peripheral nervous system neoplasm	0.000231	0.000388	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00023	0.000387	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	0.000228	0.000384	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000227	0.000383	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	0.000227	0.000383	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—AKT1—peripheral nervous system neoplasm	0.000227	0.000383	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ENO2—peripheral nervous system neoplasm	0.000227	0.000383	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	0.000225	0.000379	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000223	0.000376	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	0.000222	0.000374	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.00022	0.000371	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	0.00022	0.000371	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000219	0.000369	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SLC2A1—peripheral nervous system neoplasm	0.000219	0.000368	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000215	0.000361	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000214	0.00036	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTPN11—peripheral nervous system neoplasm	0.000213	0.000359	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000209	0.000351	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—MYC—peripheral nervous system neoplasm	0.000206	0.000346	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—peripheral nervous system neoplasm	0.000202	0.000341	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.000201	0.000339	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	0.000197	0.000332	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000194	0.000326	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—BCHE—peripheral nervous system neoplasm	0.000192	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of mRNA—AKT1—peripheral nervous system neoplasm	0.000192	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	0.00019	0.000321	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000183	0.000308	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ERBB2—peripheral nervous system neoplasm	0.000182	0.000307	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HGF—peripheral nervous system neoplasm	0.000182	0.000306	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TH—peripheral nervous system neoplasm	0.000181	0.000304	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.00018	0.000303	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000179	0.000301	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000175	0.000295	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000174	0.000293	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000171	0.000288	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ERBB2—peripheral nervous system neoplasm	0.000168	0.000283	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000165	0.000277	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of RNA—AKT1—peripheral nervous system neoplasm	0.000164	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.000155	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.000154	0.000259	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000152	0.000256	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000152	0.000256	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	0.000149	0.000251	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000149	0.000251	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GNAS—peripheral nervous system neoplasm	0.000147	0.000248	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000145	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000145	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	0.000143	0.00024	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000141	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NRAS—peripheral nervous system neoplasm	0.000139	0.000234	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000137	0.00023	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000134	0.000226	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MYC—peripheral nervous system neoplasm	0.000134	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PTPN11—peripheral nervous system neoplasm	0.000132	0.000223	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MYC—peripheral nervous system neoplasm	0.000128	0.000216	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NRAS—peripheral nervous system neoplasm	0.000128	0.000216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000123	0.000208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTPN11—peripheral nervous system neoplasm	0.000122	0.000206	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MYC—peripheral nervous system neoplasm	0.000119	0.000201	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000118	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—peripheral nervous system neoplasm	0.000116	0.000196	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000111	0.000187	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000111	0.000187	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—peripheral nervous system neoplasm	0.00011	0.000185	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000108	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000107	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERBB2—peripheral nervous system neoplasm	0.000105	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HRAS—peripheral nervous system neoplasm	0.000101	0.000171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.0001	0.000168	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—AKT1—peripheral nervous system neoplasm	9.81e-05	0.000165	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.81e-05	0.000165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERBB2—peripheral nervous system neoplasm	9.67e-05	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HRAS—peripheral nervous system neoplasm	9.37e-05	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.97e-05	0.000151	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AKT1—peripheral nervous system neoplasm	8.96e-05	0.000151	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—AKT1—peripheral nervous system neoplasm	8.91e-05	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AKT1—peripheral nervous system neoplasm	8.83e-05	0.000149	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.72e-05	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.57e-05	0.000144	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.35e-05	0.000141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AKT1—peripheral nervous system neoplasm	8.27e-05	0.000139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NRAS—peripheral nervous system neoplasm	7.97e-05	0.000134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MYC—peripheral nervous system neoplasm	7.38e-05	0.000124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NRAS—peripheral nervous system neoplasm	7.35e-05	0.000124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.86e-05	0.000116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MYC—peripheral nervous system neoplasm	6.85e-05	0.000115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.77e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.56e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.38e-05	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.2e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.14e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HRAS—peripheral nervous system neoplasm	5.83e-05	9.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.79e-05	9.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.63e-05	9.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HRAS—peripheral nervous system neoplasm	5.38e-05	9.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.15e-05	8.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AKT1—peripheral nervous system neoplasm	5.15e-05	8.66e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—AKT1—peripheral nervous system neoplasm	5.12e-05	8.62e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.8e-05	8.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKT1—peripheral nervous system neoplasm	4.75e-05	8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AKT1—peripheral nervous system neoplasm	3.98e-05	6.7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.94e-05	6.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.77e-05	6.34e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.33e-05	5.6e-05	CbGpPWpGaD
